Fresenius Medical Care AG (FMS) Long-Term Deferred Tax (2009 - 2025)

Fresenius Medical Care AG (FMS) has 17 years of Long-Term Deferred Tax data on file, last reported at $275.4 million in Q4 2025.

• In Q4 2025, Long-Term Deferred Tax rose 12.27% year-over-year to $275.4 million; the TTM figure through Dec 2025 stood at $275.4 million (up 12.27% YoY), while the FY2025 annual figure was $275.4 million, up 12.27% from the prior year.
• Long-Term Deferred Tax rose to $275.4 million in Q4 2025, from $245.3 million in the prior quarter.
• Across five years, Long-Term Deferred Tax topped out at $360.8 million in Q4 2021 and bottomed at $245.3 million in Q4 2024.
• A 5-year average of $301.2 million and a median of $305.5 million in 2023 frame the typical range for Long-Term Deferred Tax.
• Annual changes were most pronounced in 2024 — Long-Term Deferred Tax decreased 19.73% — and 2025, when it grew 12.27%.
• Year by year, Long-Term Deferred Tax stood at $360.8 million in 2021, then fell by 11.57% to $319.0 million in 2022, then fell by 4.23% to $305.5 million in 2023, then fell by 19.73% to $245.3 million in 2024, then climbed by 12.27% to $275.4 million in 2025.
• The last three Long-Term Deferred Tax figures came in at $275.4 million (Q4 2025), $245.3 million (Q4 2024), and $305.5 million (Q4 2023), per Business Quant data.

Peer Comparison